Top ▲
Target not currently curated in GtoImmuPdb
Target id: 1967
Nomenclature: cyclin dependent kinase 14
Abbreviated Name: CDK14
Family: TAIRE subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 469 | 7q21.13 | CDK14 | cyclin dependent kinase 14 | |
Mouse | - | 469 | 5 A1 | Cdk14 | cyclin dependent kinase 14 | |
Rat | - | 279 | 4q12-q13 | Cdk14 | cyclin-dependent kinase 14 |
Previous and Unofficial Names |
cell division protein kinase 14 | PFTAIRE protein kinase 1 | PFTAIRE1 | PFTK1 |
Database Links | |
Alphafold | O94921 (Hs), O35495 (Mm) |
BRENDA | 2.7.11.22 |
ChEMBL Target | CHEMBL6162 (Hs) |
Ensembl Gene | ENSG00000058091 (Hs), ENSMUSG00000028926 (Mm), ENSRNOG00000007151 (Rn) |
Entrez Gene | 5218 (Hs), 18647 (Mm), 362316 (Rn) |
Human Protein Atlas | ENSG00000058091 (Hs) |
KEGG Enzyme | 2.7.11.22 |
KEGG Gene | hsa:5218 (Hs), mmu:18647 (Mm), rno:362316 (Rn) |
OMIM | 610679 (Hs) |
Pharos | O94921 (Hs) |
RefSeq Nucleotide | NM_012395 (Hs), NM_011074 (Mm), NM_001108617 (Rn) |
RefSeq Protein | NP_036527 (Hs), NP_035204 (Mm), NP_001102087 (Rn) |
UniProtKB | O94921 (Hs), O35495 (Mm) |
Wikipedia | CDK14 (Hs) |
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: PFTK1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
TAIRE subfamily: cyclin dependent kinase 14. Last modified on 18/08/2014. Accessed on 08/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1967.